维普期刊资源整合服务平台（V6.5）

130篇 您的检索式：作者名="Standl E"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Subarachnoid sufentanil for early postoperative pain management in orthopedic patients:a placebo-controlled,double-blind study using spinal microcatheters显示文摘	Horn E Luckmann M	2001	Anesthesiology2001，94，2：	1
2	Alpha-glucosidase inhibitors 2012-cardiovas- cular considerations and trial evaluation 显示文摘	Standl E Schnell O	2012	Diab Vasc Dis Res2012，9，3：	1
3	Predictors of 10-year macrovascular and overall mortality in patients withNIDDM: the Munich General Practitioner Project 显示文摘	Standl E Balletshofer B Dahl B	1996	Diabetologia1996，39，12：	1
4	Guidelines on diabetes, pre-diabetes, and cardiovascular diseases 显示文摘	GRUPO DE TRABAJO SOBRE DIABETES Y ENFERMEDADES CARDIOVASCULARES DE LA SOCIEDAD EUROPEA DE CARDIOLOGIA Y DE LA SOCIEDAD EUROPEA PARA EL ESTUDIO DE LA DIABETES RYDEN L STANDL E	2007	Rev Esp Cardiol (西班牙文)2007，60，5：	1
5	Antibodies to bovine serum albumin (BSA)in type 1 diabetes and other autoimmune disorders显示文摘	Fuchtenbusch M Karges W Standl E	1997	Exp Clin EndocrinolDiabetes1997，105，：	1
6	The role of oral antidiabetic agents :why and when to use an early-phase insulin se- cretion agent in type 2 diabetes mellitus显示文摘	Standl E Ftichtenbusch M	2003	Diabetologia2003，46，1：	1
7	Twelve and 52 week efficacy of the dipcptidyl peptidase Ⅳ inhibitor LAF237 in metformin-treated patients with type 2 diabetes 显示文摘	Ahren B Gomis R Standl E	2004	Diabetes Care2004，27，12：	1
8	Microalbuminuria in a random cohort of recently diagnosed Type 2 diabetic patients living in the Greater Munich area显示文摘	Standl E Stiegler H	1993	Diabetologia1993，36，：	1
9	A new look at the heart in diabetes mellitus:from ailing to failing显示文摘	Standl E Schnell O	2000	Diabetologia2000，43，12：	1
10	Subarachnoid sufentanil for early postoperative pain management in orthopedic patients: a placebocontrolled, double-bline study using spinal microeatheters 显示文摘	Standl T G Horn E Luckmann M	2001	Anesthesiology2001，94，2：	1
11	Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes显示文摘	Ahrén B Gomis R Standl E	2004	Diabetes Care2004，27，12：	1
12	The role of oral antidiabetic agents:why and when to use an early-phase insulin secretion agent in Type Ⅱ diabetes mellitus显示文摘	Standl E Fuchtenbusch M	2003	Diabetologia2003，46，1：	1
13	A look at the heart in diabetes melli tus : from failing to failing 显示文摘	Standl E Schnell O	2000	Diabetolia2000，43，12：	1
14	Guidelines on dia- betes, prdiabetes, and cardiovascular diseases: Executive summary- the task force on diabetes and cardiovascular diseases of the European society of cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)显示文摘	Ryden L Standl E Bartnik M	2007	Eur Heart J2007，28，1：	1
15	Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes:an assessment of treatment flexibility显示文摘	Standl E Maxeiner S Raptis S	2006	Horm Metab Res2006，38，3：	1
16	The importance of beta-cel management in type 2 diabetes显示文摘	Standl E		0，，：	1
17	Is the current therapeutic armanmentarium in diabetes enough to control the epidemic and its consequences?What are the current shortcomings?显示文摘	Giugliano D Standl E Vilsboll T	2009	Acta Diabetol2009，46，3：	1
18	High serum insulin conceratrations in relation toother cardiovascular risk factors in macrovasculag disease of type 2 diabetes显示文摘	Standl E Janka HU	1985	Horm M etab Res1985，，：	1
19	Predictors of 10-year macrovascular and overall mortality in patients with NIDDM:the munich general practioner project显示文摘	Balletshofer B Dahl B	1996	Diabetologia1996，39，12：	1
20	The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology(ESC) and of the European Association for the study of Diabetes(EASD)显示文摘	Ryden L Standl E		0，，01：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示